pristane has been researched along with Fetal Growth Retardation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akbar, MIA; Bachnas, MA; Chouw, A; Dachlan, EG; Dekker, GA; Mudigdo, A; Purwanto, B; Sartika, CR; Sulistyowati, S; Widjiati, W | 1 |
1 other study(ies) available for pristane and Fetal Growth Retardation
Article | Year |
---|---|
Mesenchymal stem cell secretome ameliorates over-expression of soluble fms-like tyrosine kinase-1 (sFlt-1) and fetal growth restriction (FGR) in animal SLE model.
Topics: Abortion, Spontaneous; Animals; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Lupus Erythematosus, Systemic; Mesenchymal Stem Cells; Mice; Models, Animal; Placenta; Placenta Growth Factor; Pregnancy; Secretome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2023 |